Synergistic effects of galantamine and memantine in attenuating scopolamine-induced amnesia in mice

Journal of Pharmacological Sciences

Volumn 120, Issue 4, 2012, Pages 305-309

  Busquet, Perrine ^a   Capurro, Valeria ^a   Cavalli, Andrea ^a,b   Piomelli, Daniele ^a,c   Reggiani, Angelo ^a   Bertorelli, Rosalia ^a  

^a ISTITUTO ITALIANO DI TECNOLOGIA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Memory impairment; Multi target; Neurodegenerative disease

Indexed keywords

GALANTAMINE; MEMANTINE; SCOPOLAMINE;

AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENTIATION; EPISODIC MEMORY; MALE; MONOTHERAPY; MOUSE; NONHUMAN; RECOGNITION; SPATIAL MEMORY; TASK PERFORMANCE;

EID: 84871521313     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.12166SC     Document Type: Article

References (17)

1. Patel L, Grossberg GT. Combination therapy for Alzheimer's disease. Drugs Aging. 2011;28:539-546.
2. Reisberg B, Doody R, Stöffler A, Schmitt F, Ferris S, Möbius HJ. Memantine in moderate-to-severe Alzheimer's disease. N Engl J Med. 2003;348:1333-1341. (Pubitemid 36384100)
3. Birks J. Cholinesterase inhibitors for Alzheimer's disease. Cochrane Database Syst Rev. 2006;25:CD005593.
4. Spowart-Manning L, van der Staay FJ. The T-maze continuous alternation task for assessing the effects of putative cognition enhancers in the mouse. Behav Brain Res. 2004;151:37-46. (Pubitemid 38501426)
5. Bevins RA, Besheer J. Object recognition in rats and mice: a one-trial non-matching-to-simple learning task to study 'recognition memantineory'. Nat Protoc. 2006;1:1306-1311.
6. Yoo DY, Woo YJ, Kim W, Nam SM, Lee BH, Yeun GH, et al. Effects of a new synthetic butyrylcholinesterase inhibitor, HBU-39, on cell proliferation and neuroblast differentiation in the hippocampal dentate gyrus in a scopolamine-induced amnesia animal model. Neurochem Int. 2011;59:722-728.
7. Drever BD, Anderson WG, Johnson H, O'Callaghan M, Seo S, Choi DY, et al. Memantine acts as a cholinergic stimulant in the mouse hippocampus. J Alzheimers Dis. 2007;12:319-333.
8. Fonnum F, Myhrer T, Paulsen RE, Wangen K, Oksengård AR. Role of glutamate and glutamate receptors in memory function and Alzheimer's disease. Ann N Y Acad Sci. 1995;757:475-486.
9. Giacobini E. Cholinesterase inhibitors stabilize Alzheimer disease. Neurochem Res. 2000;25:1185-1190.
10. Van Dam D, De Deyn PP. Cognitive evaluation of disease-modifying efficacy of galantamine and memantine in the APP23 model. Eur Neuropsychopharmacol. 2006;16:59-69. (Pubitemid 43005096)
11. Csernansky JG, Martin M, Shah R, Bertchume A, Colvin J, Dong H. Cholinesterase inhibitors ameliorate behavioral deficits induced by MK-801 in mice. Neuropsychopharmacology. 2005;30:2135-2143. (Pubitemid 41643964)
12. Woodruff-Pak DS, Vogel RW 3rd, Wenk GL. Mecamylamine interactions with galantamine and donepezil: effects on learning, acetylcholinesterase, and nicotinic acetylcholine receptors. Neuroscience. 2003;117:439-447. (Pubitemid 36259758)
13. Penner J, Rupsingh R, Smith M, Wells JL, Borrie MJ, Bartha R. Increased glutamate in the hippocampus after galantamine treatment for Alzheimer disease. Prog Neuropsychopharmacol Biol Psychiatry. 2010;34:104-110.
14. Santos MD, Alkondon M, Pereira EF, Aracava Y, Eisenberg HM, Maelicke A, et al. The nicotinic allosteric potentiating ligand galantamine facilitates synaptic transmission in the mammalian central nervous system. Mol Pharmacol. 2002;61:1222-1234. (Pubitemid 34441788)
15. Fujikawa K, Nakamichi N, Kato S, Fukumori R, Hida M, Takarada T, et al. Delayed mitochondrial membrane potential disruption by ATP in cultured rat hippocampal neurons exposed to N-methyl-D-aspartate. J Pharmacol Sci. 2012;119:20-29.
16. Ago Y, Koda K, Takuma K, Matsuda T. Pharmacological aspects of the acetylcholinesterase inhibitor galantamine. J Pharmacol Sci. 2011;116:6-17.
17. Shearman E, Rossi S, Szasz B, Juranyi Z, Fallon S, Pomara N, et al. Changes in cerebral neurotransmitters and metabolites induced by acute donepezil and memantine administrations: a microdialysis study. Brain Res Bull. 2006;69:204-213. (Pubitemid 43375876)